| Increased α-synuclein aggregation following limited cleavage by certain matrix metalloproteinases J Levin, A Giese, K Boetzel, L Israel, T Högen, G Nübling, H Kretzschmar, ... Experimental neurology 215 (1), 201-208, 2009 | 114 | 2009 |
| Decision making at the end of life—cancer patients’ and their caregivers’ views on artificial nutrition and hydration J Bükki, T Unterpaul, G Nübling, RJ Jox, S Lorenzl Supportive Care in Cancer 22 (12), 3287-3299, 2014 | 89 | 2014 |
| Alzheimer's disease in Down syndrome: An overlooked population for prevention trials A Strydom, A Coppus, R Blesa, A Danek, J Fortea, J Hardy, J Levin, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 87 | 2018 |
| Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis GS Nübling, E Mie, RM Bauer, M Hensler, S Lorenzl, A Hapfelmeier, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (3-4), 174-179, 2014 | 76 | 2014 |
| Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders M Zech, G Nübling, F Castrop, A Jochim, EC Schulte, B Mollenhauer, ... PloS one 8 (12), e82879, 2013 | 76 | 2013 |
| Niemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative M Zech, G Nübling, F Castrop, A Jochim, EC Schulte | 76* | 2013 |
| Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level G Nübling, B Bader, J Levin, J Hildebrandt, H Kretzschmar, A Giese Molecular neurodegeneration 7 (1), 1-13, 2012 | 73 | 2012 |
| Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis J Hildebrandt, E Yalcin, HG Bresser, G Cinel, M Gappa, A Haghighi, ... Orphanet journal of rare diseases 9 (1), 1-9, 2014 | 71 | 2014 |
| [18F]-THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy M Brendel, S Schönecker, G Höglinger, S Lindner, J Havla, J Blautzik, ... Frontiers in aging neuroscience 9, 440, 2018 | 66 | 2018 |
| Single particle analysis of tau oligomer formation induced by metal ions and organic solvents B Bader, G Nübling, A Mehle, S Nobile, H Kretzschmar, A Giese Biochemical and biophysical research communications 411 (1), 190-196, 2011 | 62 | 2011 |
| Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation G Nübling, J Levin, B Bader, L Israel, K Bötzel, S Lorenzl, A Giese Experimental neurology 237 (2), 470-476, 2012 | 60 | 2012 |
| Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro T Birnbaum, J Hildebrandt, G Nuebling, P Sostak, A Straube Journal of neuro-oncology 105 (1), 57-65, 2011 | 60 | 2011 |
| Gait analysis in PSP and NPH: dual-task conditions make the difference C Selge, F Schoeberl, A Zwergal, G Nuebling, T Brandt, M Dieterich, ... Neurology 90 (12), e1021-e1028, 2018 | 45 | 2018 |
| Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study M Carmona-Iragui, D Alcolea, I Barroeta, L Videla, L Muñoz, KL Van Pelt, ... The Lancet Neurology 20 (8), 605-614, 2021 | 39 | 2021 |
| Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers GS Nübling, J Levin, B Bader, S Lorenzl, A Hillmer, T Högen, F Kamp, ... PLoS One 9 (6), e98906, 2014 | 37 | 2014 |
| Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha GS Nübling, J Levin, B Bader, S Lorenzl, A Hillmer | 37* | 2014 |
| PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy G Nuebling, M Hensler, S Paul, A Zwergal, A Crispin, S Lorenzl Journal of neurology 263 (8), 1565-1574, 2016 | 29 | 2016 |
| Managing advanced progressive supranuclear palsy and corticobasal degeneration in a palliative care unit: admission triggers and outcomes J Bükki, G Nübling, S Lorenzl American Journal of Hospice and Palliative Medicine® 33 (5), 477-482, 2016 | 29 | 2016 |
| Palliative treatment of chronic neurologic disorders S Lorenzl, G Nübling, KM Perrar, R Voltz Handbook of clinical neurology 118, 133-139, 2013 | 29 | 2013 |
| Clinical routine FDG-PET imaging of suspected progressive supranuclear palsy and corticobasal degeneration: a gatekeeper for subsequent tau-PET imaging? L Beyer, J Meyer-Wilmes, S Schönecker, J Schnabel, E Brendel, C Prix, ... Frontiers in neurology 9, 483, 2018 | 26 | 2018 |
